Compare Cadila Healthcare with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DR. REDDYS LAB - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DR. REDDYS LAB CADILA HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 27.2 37.6 72.3% View Chart
P/BV x 4.8 5.1 92.6% View Chart
Dividend Yield % 0.7 0.5 140.4%  

Financials

 CADILA HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
DR. REDDYS LAB
Mar-20
CADILA HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3523,363 10.5%   
Low Rs2072,352 8.8%   
Sales per share (Unadj.) Rs139.21,054.2 13.2%  
Earnings per share (Unadj.) Rs11.8121.9 9.6%  
Cash flow per share (Unadj.) Rs18.6190.2 9.8%  
Dividends per share (Unadj.) Rs3.5025.00 14.0%  
Dividend yield (eoy) %1.30.9 143.2%  
Book value per share (Unadj.) Rs101.4938.7 10.8%  
Shares outstanding (eoy) m1,023.74166.17 616.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.02.7 74.0%   
Avg P/E ratio x23.723.4 101.3%  
P/CF ratio (eoy) x15.015.0 100.2%  
Price / Book Value ratio x2.83.0 90.6%  
Dividend payout %29.820.5 145.1%   
Avg Mkt Cap Rs m286,033474,831 60.2%   
No. of employees `00013.421.7 61.9%   
Total wages/salary Rs m24,14533,802 71.4%   
Avg. sales/employee Rs Th10,632.78,091.0 131.4%   
Avg. wages/employee Rs Th1,801.21,561.3 115.4%   
Avg. net profit/employee Rs Th898.5935.8 96.0%   
INCOME DATA
Net Sales Rs m142,531175,170 81.4%  
Other income Rs m1,1396,206 18.4%   
Total revenues Rs m143,670181,376 79.2%   
Gross profit Rs m24,19824,421 99.1%  
Depreciation Rs m6,96511,348 61.4%   
Interest Rs m3,418983 347.7%   
Profit before tax Rs m14,95418,296 81.7%   
Minority Interest Rs m2880-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198-1,403 -227.9%   
Profit after tax Rs m12,04420,260 59.4%  
Gross profit margin %17.013.9 121.8%  
Effective tax rate %21.4-7.7 -278.9%   
Net profit margin %8.511.6 73.1%  
BALANCE SHEET DATA
Current assets Rs m87,154125,991 69.2%   
Current liabilities Rs m82,69472,141 114.6%   
Net working cap to sales %3.130.7 10.2%  
Current ratio x1.11.7 60.3%  
Inventory Days Days7173 97.7%  
Debtors Days Days94105 89.5%  
Net fixed assets Rs m133,23683,854 158.9%   
Share capital Rs m1,024831 123.2%   
"Free" reserves Rs m102,733155,157 66.2%   
Net worth Rs m103,757155,988 66.5%   
Long term debt Rs m32,1461,304 2,465.2%   
Total assets Rs m236,866232,253 102.0%  
Interest coverage x5.419.6 27.4%   
Debt to equity ratio x0.30 3,706.2%  
Sales to assets ratio x0.60.8 79.8%   
Return on assets %6.59.1 71.4%  
Return on equity %11.613.0 89.4%  
Return on capital %13.712.6 108.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m52,75284,193 62.7%   
Fx outflow Rs m14,50439,616 36.6%   
Net fx Rs m38,24844,577 85.8%   
CASH FLOW
From Operations Rs m25,05429,841 84.0%  
From Investments Rs m-10,123-4,923 205.6%  
From Financial Activity Rs m-10,942-25,159 43.5%  
Net Cashflow Rs m3,989-266 -1,499.6%  

Share Holding

Indian Promoters % 74.8 25.5 293.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 5.4 153.7%  
FIIs % 5.9 35.3 16.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 11.0 15.3 71.9%  
Shareholders   44,069 75,885 58.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Marginally Higher; ONGC and M&M Top Gainers(09:30 am)

Asian share markets are trading on a positive note today as investors anticipated the start of corporate earnings seasons.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

India: recovery stalled by vaccine games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Apr 13, 2021 10:57 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - WOCKHARDT COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS